Treatment options in Waldenström’s macroglobulinaemia: the role of the purine analogues

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.6, 2001-06, pp. : 945-952

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Purine Nucleoside Analogues for the Treatment of Hematological Malignancies: Pharmacology and Clinical Applications

Current Cancer Drug Targets, Vol. 5, Iss. 6, 2005-09 ,pp. : 421-444

Bentham Science Publishers

Access to resources Recommend Favorite

Purine analogues as antiparasitic agents

By Lawton Philippe

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 8, 2005-08 ,pp. : 987-994

Informa Healthcare

Access to resources Recommend Favorite

A Role of GABA Analogues in the Treatment of Neurological Diseases

Current Medicinal Chemistry, Vol. 17, Iss. 22, 2010-08 ,pp. : 2338-2347

Bentham Science Publishers

Access to resources Recommend Favorite

A review of the treatment options for Huntington’s disease

By Bonelli Raphael M Hofmann Peter

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 767-776

Informa Healthcare

Access to resources Recommend Favorite

Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 7, 2011-01 ,pp. : 849-862

Bentham Science Publishers

Access to resources Recommend Favorite